1. Home
  2. KLTO vs ADGM Comparison

KLTO vs ADGM Comparison

Compare KLTO & ADGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • ADGM
  • Stock Information
  • Founded
  • KLTO 2019
  • ADGM 2011
  • Country
  • KLTO United States
  • ADGM United States
  • Employees
  • KLTO N/A
  • ADGM N/A
  • Industry
  • KLTO
  • ADGM
  • Sector
  • KLTO
  • ADGM
  • Exchange
  • KLTO NYSE
  • ADGM NYSE
  • Market Cap
  • KLTO 5.9M
  • ADGM 19.7M
  • IPO Year
  • KLTO N/A
  • ADGM N/A
  • Fundamental
  • Price
  • KLTO $1.33
  • ADGM $1.42
  • Analyst Decision
  • KLTO
  • ADGM
  • Analyst Count
  • KLTO 0
  • ADGM 0
  • Target Price
  • KLTO N/A
  • ADGM N/A
  • AVG Volume (30 Days)
  • KLTO 15.4M
  • ADGM 42.7K
  • Earning Date
  • KLTO 08-15-2025
  • ADGM 08-25-2025
  • Dividend Yield
  • KLTO N/A
  • ADGM N/A
  • EPS Growth
  • KLTO N/A
  • ADGM N/A
  • EPS
  • KLTO N/A
  • ADGM N/A
  • Revenue
  • KLTO N/A
  • ADGM $576,000.00
  • Revenue This Year
  • KLTO N/A
  • ADGM N/A
  • Revenue Next Year
  • KLTO N/A
  • ADGM N/A
  • P/E Ratio
  • KLTO N/A
  • ADGM N/A
  • Revenue Growth
  • KLTO N/A
  • ADGM 116.54
  • 52 Week Low
  • KLTO $0.11
  • ADGM $0.63
  • 52 Week High
  • KLTO $3.91
  • ADGM $9.34
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • ADGM N/A
  • Support Level
  • KLTO N/A
  • ADGM N/A
  • Resistance Level
  • KLTO N/A
  • ADGM N/A
  • Average True Range (ATR)
  • KLTO 0.00
  • ADGM 0.00
  • MACD
  • KLTO 0.00
  • ADGM 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • ADGM 0.00

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About ADGM ADAGIO MEDICAL HOLDINGS INC

Adagio Medical Holdings Inc is an innovator in catheter ablation technologies for the treatment of cardiac arrhythmias. The company focuses on developing cryoablation technologies that create contiguous, transmural lesions to treat cardiac arrhythmias, including paroxysmal and persistent atrial fibrillation, atrial flutter, and ventricular tachycardia.

Share on Social Networks: